Equities

Sera Prognostics Inc

SERA:NMQ

Sera Prognostics Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)6.74
  • Today's Change-0.89 / -11.66%
  • Shares traded286.76k
  • 1 Year change+242.13%
  • Beta0.9466
Data delayed at least 15 minutes, as of Nov 08 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 16-Nov-23
  • 15-Aug-24
  • 19-Sep-24
  • 17-Oct-24
  • 07-Nov-24
Select bar for recommendation details.
Recommendations07-Nov-24
Buy1
Outperform1
Hold0
Sell0
Strong Sell0

Share price forecast in USD

The one analyst offering a 12 month price target expects Sera Prognostics Inc share price to fall to 2.75 in the next year from the last price of 6.74.
High-59.2%2.75
Med-59.2%2.75
Low-59.2%2.75

Earnings history & estimates in USD

On Nov 06, 2024, Sera Prognostics Inc reported 3rd quarter 2024 losses of -0.24 per share.
The next earnings announcement is expected on Mar 24, 2025.
Average growth rate-1.17%
Sera Prognostics Inc reported annual 2023 losses of -1.16 per share on Mar 20, 2024.
Average growth rate+28.75%
More ▼

Revenue history & estimates in USD

Sera Prognostics Inc had 3rd quarter 2024 revenues of 29.00k. This missed the 85.00k consensus estimate of the 2 analysts following the company. This was 71.00% below the prior year's 3rd quarter results.
Average growth rate-27.18%
Sera Prognostics Inc had revenues for the full year 2023 of 306.00k. This was 14.18% above the prior year's results.
Average growth rate+120.50%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.